The Impact of Aging on the Lung Alveolar Environment, Predetermining Susceptibility to Respiratory Infections.

Respiratory infections are one of the top causes of death in the elderly population, displaying susceptibility factors with increasing age that are potentially amenable to interventions. We posit that with increasing age there are predictable tissue-specific changes that prevent the immune system from working effectively in the lung. This mini-review highlights recent evidence for altered local tissue environment factors as we age focusing on increased tissue oxidative stress with associated immune cell changes, likely driven by the byproducts of age-associated inflammatory disease. Potential intervention points are presented.

General Introduction

The elderly population will double to 2 billion by 2050 (Publications, 2019). Age-associated cellular decline begins to be notable in our 40s and accelerates in our 60s (Jones et al., 2002; Massudi et al., 2012; López-Otín et al., 2013; Schneider et al., 2021). While aging represents a complex progression involving many physiological and physical changes in metabolism and endurance, the field of aging is advancing steadily, with greater understanding of the changes in cellular processes, and the critical role that tissue-specific health plays in how we age. However, the molecular events driving age-dependent physiological and physical decline and the molecular thresholds at the tissue and cellular levels that determine the point(s) of no return or so-called tipping point(s), resulting in non-recoverable tissue or systemic dysfunction are largely unknown. Here, we will highlight how and when some aspects of age-associated cellular decline occur in the pulmonary space, a critical organ that interfaces directly with the environment and is prone to infections. Such information can help develop therapeutic strategies to enhance healthy pulmonary aging in a timely manner to mitigate or delay deleterious events.

The Lung Alveolar Environment During Aging

As we age, there are changes in the physical environment and mechanical function of the lung that influence breathing and contribute to the increased susceptibility of the elderly to many infections (Schneider et al., 2021; Dyer, 2012; Vaz Fragoso and Lee, 2012; Haynes, 2020). Aging-related changes in the respiratory system generally include structural changes in the thoracic cage and lung parenchyma, abnormal lung function including ventilation and gas exchange abnormalities, decreased exercise capacity, airway nerve impairment, and reduced respiratory muscle strength and elasticity; each of which affect the cough reflex, sneezing or breathing (Figure 1) (Schneider et al., 2021). These progressive changes cause a decline in lung function and impaired immunological responses (Janssens et al., 1999; Lowery et al., 2013; Sharma and Goodwin, 2006; van Oostrom et al., 2018; Chalise, 2019; Thomas et al., 2019; Cho and Stout-Delgado, 2020; Haynes, 2020). To avoid cumulative damage, lung-resident cells rely on a robust homeostatic balance of stress response and associated inflammatory pathways; however, there is likely a tipping point (Figure 2), where age-associated changes finally overwhelm these control mechanisms leading to an increasing oxidative environment and irreversible damage (Moliva et al., 2014; Schöttker et al., 2015; Schneider et al., 2021). These factors combined with reduced lung-specific homeostatic immune activities facilitate entry of pathogens into the upper and lower respiratory tract leading to an increased propensity for infection (Vaz Fragoso and Lee, 2012; Haynes, 2020).

FIGURE 1

Characteristics of the Aging lung. Mechanical, physiological and immunological (increased inflammation/immunosenescence) changes in the lung that take place in elderly individuals increasing the risk of airway clearance failure and susceptibility to respiratory infections.

FIGURE 2

Oxidative and inflammatory environment in the lung leads to immunological impartment and susceptibility to respiratory infections. As we age, cellular senescence occurs. There are also alterations in cellular metabolic processes involving energy production and consumption among others. These events lead to an accumulation of oxidative stressors (ROS/NOS) in the lumen of alveolar compartment cells (left boxes) causing increased cellular inflammation that cannot be efficiently regulated. Subsequently, this accumulation of oxidative stressors outflows into the alveolar environment (e.g., upon cell death) (right boxes). This outflow causes lung tissue inflammation and damage, and also drives the oxidation and impairment of lung soluble and cellular immunomodulators. Altogether, these events contribute to the elderly becoming susceptible to acute and chronic respiratory infections and diseases.

The Lung Mucosa

The alveolus is lined with lung mucosa, composed of a surfactant lipid layer and an aqueous-hypophase called alveolar lining fluid (ALF) (Torrelles and Schlesinger, 2017). ALF contains innate soluble components with the primary role of maintaining proper pulmonary function (Notter, 2000; Fronius et al., 2012; Torrelles and Schlesinger, 2017). Our studies and others indicate that lung tissue in the elderly (in humans and mice) has a high basal inflammation and oxidative stress that leads to dysfunction of critical innate soluble and cellular components that could drive host susceptibility to respiratory infections and diseases [e.g., influenza, pneumonia, tuberculosis (TB)] (Toapanta and Ross, 2009; Shivshankar et al., 2011; Canan et al., 2014; Moliva et al., 2014; Piergallini and Turner, 2018a; Keilich et al., 2019; Bulut et al., 2020; Harpur et al., 2021). Thus, defining when and how these changes occur at the cellular and molecular level is critical to understand age-associated lung-specific pathologies and aging in general. Published studies demonstrate that the elderly have basal inflammation (e.g., elevated levels of TNF-α, IL-6, IL-1β, and IL-12), as well as increased protein oxidation with elevated levels of proteins with carbonyl and nitrotyrosine residues indicative of oxidation by reactive oxygen (ROS) and nitrogen (RNS) species, respectively, and reduced protein function in the lung (Moliva et al., 2014; Moliva et al., 2019). Indeed, studies focused on studying the lung mucosa composition in the elderly showed increased levels of innate surfactant proteins and components of the complement system, but with diminished function (Moliva et al., 2014). Dysfunction of innate soluble components of the lung mucosa is linked directly to high levels of oxidative stress [(e.g., elevated levels of ROS/RNS and myeloperoxidase (MPO)], which impair their function, and oxidizes critical surfactant lipids involved in keeping the lung alveolar space integrity and functionality (Moliva et al., 2014).

Studies addressing the impact of the human lung mucosa from the elderly on microbial pathogenesis are very limited. Upon reaching the alveolar space, respiratory pathogens come in close contact with the lung mucosa before and after their encounter with host alveolar compartment cells [e.g., type 1 and 2 epithelial cells (ATs) and alveolar macrophages (AMs)]. Our previous studies show that homeostatic innate soluble components of the ALF can quickly alter the cell envelope surface of pathogens upon contact, influencing subsequent pathogen-host cell interactions and infection outcomes (Arcos et al., 2011; Arcos et al., 2015; Arcos et al., 2017; Hill et al., 2017; Scordo et al., 2017; Scordo et al., 2019; Haynes, 2020). Alterations of a pathogen cell envelope is mainly due to homeostatic hydrolytic activities (hydrolases), primarily responsible for maintaining lung health, that modify pathogens and influence their subsequent interactions with host cells (Arcos et al., 2011; Hill et al., 2017; Torrelles and Schlesinger, 2017). In this context we have demonstrated that ALF from healthy 60 + year old individuals is dysfunctional, with loss of homeostatic hydrolytic capacity and impaired innate soluble responses linked to high local oxidative stress, compared to healthy 18- to 45-year-old individuals (Moliva et al., 2014). Importantly, a pathogen such as Mycobacterium tuberculosis exposed to ALF from the elderly demonstrates increased virulence in vitro and in vivo indicating that impaired innate responses in the lung may play a critical role in susceptibility to respiratory infection as we age (Moliva et al., 2019). In this context, two major cell populations in the alveolar space are AMs and ATs. Our studies indicate that after exposure to ALF from the elderly, M. tuberculosis doubles its intracellular growth rate in AMs, further indicating the impact of ALF dysfunction as we age (Moliva et al., 2019). Thus, efforts to mitigate oxidative stress in the lungs prior to a so-called tipping point(s) may reduce inflammation and aid in functional recovery of important innate immune-modulators against respiratory pathogens (Piergallini and Turner, 2018b; Iddir et al., 2020; Michaeloudes et al., 2020).

Evidence for a higher oxidative environment of the elderly lung is also supported by proteomics studies in other tissues and in-vitro studies with purified mitochondria from old mice (Moliva et al., 2014; Stauch et al., 2015; Ingram and Chakrabarti, 2016; Gómez-Serrano et al., 2018; Moliva et al., 2019; Ubaida-Mohien et al., 2019; Yang et al., 2019). However, the mechanism behind elevated oxidative stress in the lungs as we age is still not completely understood. Based on studies in other tissues, the oxidative pulmonary environment may be attributed in part to mitochondrial dysfunction. Mitochondria are primarily responsible for producing ATP (Anderson et al., 2019) and are found in greater numbers in tissues and organs where energy needs are high (e.g., muscle, heart, brain, liver and kidney). However, few studies have focused on the lung despite its direct exposure to oxygen, large consumption of energy (Liu and Summer, 2019), and high risk of dysfunction and disease in older age as mitochondrial function declines (Short et al., 2005; Kim et al., 2015; Haas, 2019; Sekhar M.D. et al., 2019). Thus, interventions to address the management of mitochondria-induced oxidative stressors (e.g. reactive oxygen and nitrogen oxidative species, ROS, NOS) in the lung tissue should mitigate lung oxidative stress and inflammation, and lead to improved resistance of the elderly to respiratory infections.

Alveolar Macrophages During Aging

Aging is associated with a weakening of immune function, called cellular immunosenescence. In addition to this process there is a baseline level of dysfunctional inflammation in old age termed inflammaging (Franceschi et al., 2000; Moliva et al., 2014; Frasca and Blomberg, 2016; Fulop et al., 2017; Lafuse et al., 2019; Moliva et al., 2019). The relationship between inflammaging and dysfunctional innate immunity is understood poorly, especially in the lung. These changes are thought to be critical to understanding why the elderly are at an increased risk of developing and succumbing to malignancies, autoimmunity (Linton and Dorshkind, 2004; Pawelec et al., 2010), and infectious diseases such as TB (Piergallini and Turner, 2018b; Lafuse et al., 2019; Moliva et al., 2019).

AMs live in a unique tissue environment and we are only now gaining insight into the local environmental factors that impact AM phenotype and function (Guth et al., 2009; Davies and Taylor, 2015; Allard et al., 2018; Papp et al., 2018; Hoeksema and Glass, 2019; Lafuse et al., 2019). AM responses enable us to maintain health (clearance of invaders) and at the same time, must dampen pro-inflammatory responses to maintain alveolar structure to enable gas exchange. Our failure to understand the cellular and molecular events underlying AM development and biology creates a critical barrier in our attempts to develop new treatment strategies that target the lung. AMs, which constitute >95% of the cells recovered by bronchoalveolar lavage in healthy individuals, are thought to play a central role in lung inflammaging due to their unique regulation by molecular factors in the lung environment.

Indeed, our studies and others have demonstrated an AM inflammatory signature in the elderly (Canan et al., 2014; Wong et al., 2017; Lafuse et al., 2019; Duong et al., 2021). Specifically, AMs from old mice express higher mRNA levels of the macrophage migration inhibitory factor (MIF), TNF-α, IFN-β, IL-10, IL-12p40, and CCL2 than young mice, and old mice also contain higher levels of MIF, IL-1β, IFN-β, and CCL2 in their alveolar lining fluid. Further, old mice have two distinct AM subpopulations, a major CD11c+ CD11b− population and a minor CD11c+ CD11b+ population; the latter is increased significantly in old mice (∼4-fold). Expression of pattern recognition receptors, antigen presentation molecules, and activation markers such as CD206, TLR2, CD16/CD32, MHC class II, and CD86 is higher in CD11c+ CD11b+ AMs, and these cells express monocytic markers such as Ly6C, CX3CR1, and CD115, suggesting monocytic origin. Old mouse purified CD11c+ CD11b+ AMs phagocytose significantly more M. tuberculosis, and express higher RNA levels of genes favoring M. tuberculosis intracellular growth. Thus, the lungs of old mice contain two distinct AM subpopulations, a defined resident subpopulation and an immigrating CD11c+ CD11b+ AM subpopulation expressing monocytic markers, a unique inflammatory signature, with enhanced M. tuberculosis phagocytosis capacity and M. tuberculosis survival. Our findings suggest that this CD11c+ CD11b+ AM subpopulation could be targeted by respiratory pathogens as a niche for replication and survival within the lung of the elderly population driving their susceptibility to respiratory infections.

Nuclear receptors (NRs) function as cellular transcription factors enabling macrophages and other myeloid cells to sense their local environment and shape their immune and metabolic responses (Murphy and Crean, 2015; Leopold Wager et al., 2019a; Bichiou et al., 2021). Drugs targeting NRs represent 16% of all drugs approved for sale in the United States in 2019, demonstrating their feasibility as host-directed therapies (HDTs) for disease management (Ricote and Glass, 2007; Santos et al., 2017; Boudreaux et al., 2019; Zhang et al., 2020). NRs are increasingly appreciated for their importance during aging (Speeckaert et al., 2014; Paillasse and de Medina, 2015; Cisneros and García-Aguirre, 2020; Xu et al., 2020). Most past studies have focused on specific NRs in cell lines or murine cells, thus their function and interactions within primary cells and the lung environment are largely unexplored. Studies using human and murine macrophages (Zollner and Trauner, 2009; Dhiman et al., 2018; Leopold Wager et al., 2019a; Leopold Wager et al., 2019b; Ning et al., 2019; Zhao et al., 2019; Zhao et al., 2020) in cancer (Zhou et al., 2014; Dhiman et al., 2018; Zhao et al., 2019), auto-immunity (Zollner and Trauner, 2009; Lee et al., 2011; Ning et al., 2019; Olson et al., 2020) and infectious diseases (Renga et al., 2012; Leopold Wager et al., 2019a; Leopold Wager et al., 2019b) have highlighted the importance of NRs in maintaining tissue homeostasis (Nagy et al., 2013; Zhao et al., 2020; Alatshan and Benkő, 2021). Several NRs are postulated to dampen pro-inflammatory networks (De Bosscher et al., 2006; Huang and Glass, 2010; Mandard and Patsouris, 2013; Li et al., 2015; Wang et al., 2017; Duez and Pourcet, 2021; Pulakazhi Venu et al., 2021; Vuttaradhi et al., 2021). Thus, NR dysfunction during aging may remove the brakes to pro-inflammatory and oxidative stress pathways with associated altered mitochondrial function as discussed above. Since NRs regulate metabolism and inflammation in a tissue-specific manner, studying NR expression and activity as well as their involvement in altering lung macrophage lipid metabolism, cellular energy homeostasis and protective immune responses during aging could help define new biological pathways that play important roles in host responses in the lung as we age.

One particularly important NR regulating AM development and function is peroxisome proliferator-activated receptor gamma (PPARγ), where our recent work has identified novel targetable PPARγ effectors that regulate inflammation and cell death pathways (Arnett et al., 2018). PPARγ endogenous ligands include eicosanoids, which are critical determinants of cellular metabolism and immune responses that exert both anti- and pro-inflammatory actions (Nagy et al., 2012; Dennis and Norris, 2015; Arnett et al., 2018; Bougarne et al., 2018), and likely play important roles in controlling cellular aging. Indeed, PPARs regulate gene expression through multiple mechanisms, including heterodimerizing with the retinoid X receptor (RXR), and binding to PPAR response elements in promoters. PPARs also trans-repress NF-κB and other transcription factors to negatively regulate pro-inflammatory pathways and stabilize the NR co-repressor NCoR, to repress gene expression (Ricote and Glass, 2007). Using macrophage-specific PPARγ knockout mice (Odegaard et al., 2007), we showed that PPARγ specifically in lung macrophages is important for controlling bacterial growth (e.g. M. tuberculosis) and limiting inflammation in vivo (Guirado et al., 2018). These findings highlight a critical role of PPARγ in controlling inflammation, yet the impact of aging on PPARγ and expression and activity of other NRs is still unclear.

Based on our knowledge in the field (Oren et al., 1963; O'Neill et al., 2016; Viola et al., 2019), several NRs are postulated to dampen pro-inflammatory networks (De Bosscher et al., 2006; Huang and Glass, 2010; Mandard and Patsouris, 2013; Papi et al., 2014; Leopold Wager et al., 2019a; Klepsch et al., 2019; Duez and Pourcet, 2021). Thus, it is plausible that NR expression and activity are altered across the continuum of age and NRs become dysfunctional; where age-related NR changes can induce aberrant lung macrophage inflammation, oxidative stress, lipid metabolism, and energy programs. Thus, modulation of NR activity with agonists or antagonists could restore healthy immune homeostasis to slow or reverse the lung health issues associated with aging, allowing for more robust protection against lung infections and inflammatory diseases.

Other Cellular Changes in the Alveolar Compartment During Aging

As we age, alveolar compartment cells become senescent due to the shortening of telomeres and the accumulation of DNA lesions driven by free oxidative radicals generated in the lung environment. AMs, interstitial macrophages, neutrophils and dendritic cells lose their microbicidal and antigen presenting capacities (Wenisch et al., 2000; Uyemura et al., 2002; Stout et al., 2005). Notably, neutrophils exhibit an alteration of their homeostatic functions that may contribute to the susceptibility to lung infections of the elderly (Barkaway et al., 2021). These include decreased phagocytosis, reduced production of ROS and extracellular traps (NETS) formation (Hazeldine et al., 2014), as well as reduced apoptosis and chemotaxis accompanied with dysregulated migration (Niwa et al., 1989; Fulop et al., 2004). Natural killer (NK) cells, which also constitute a first line of defense against virus-infected and malignant cells (Hazeldine and Lord, 2013) change with age. In particular, NK cells become dysfunctional for secretion of regulatory and anti-microbial responses, cytotoxic capacity, and elimination of transformed and senescent cells (Hazeldine and Lord, 2013). These alterations have implications for age-associated immune responses in the alveolar space of elderly individuals. Indeed, several studies implicate NK dysfunction to increased cases of TB reactivation in the elderly, as well as poor resolution of inflammatory disorders and increased incidence of respiratory infections (Hazeldine and Lord, 2013).

With regard to adaptive immunity, the number of B cells decrease during aging leading to reduced immunoglobulin diversity and affinity (Han et al., 2003; McElhaney et al., 2016; Frasca et al., 2020). Age associated inflammation is also known to impact B cell function (Hagen and Derudder, 2020), impacting germinal center formation and cytokine mediated signaling. Systemic T cell proliferation is impaired, repertoire diversity decreases, homeostasis is modified, intracellular signal transduction capability is dysregulated, and T cells produce less cytokines and are less cytotoxic (Fülöp et al., 1999; Voehringer et al., 2002; Ouyang et al., 2003; Naylor et al., 2005). Indeed, CD4 and CD8 T cells show age-related changes in function (Maue et al., 2009; Lorenzo et al., 2018; Haynes, 2020), with changes in CD4 T cells during aging (Haynes and Swain, 2012; Lee et al., 2012) influencing both CD8 T function and B cell antibody production in response to influenza (Maue et al., 2009; Toapanta and Ross, 2009; Lorenzo et al., 2018). For CD4 T cells, intrinsic defects promote delayed adaptive immune responses and recovery from influenza infection, but adoptive transfer studies have also shown that extrinsic factors also contribute to poor T cell function in the lung. This eludes to the influence of the myriad of changes in the alveolar space, such as oxidation of innate molecules or altered AM function, with increasing age that have wide reaching effect including an influence on adaptive immune function. Significant to lung function in older age, memory T cell populations start to lose their function, most notable in tissue specific resident memory CD8 T cells (CD8 TRM cells) (Schenkel et al., 2014; McMaster et al., 2015; Goplen et al., 2020) (Hakim and Gress, 2007). CD8 TRM cells from old mice have been shown to drive lung fibrosis following influenza, SARS-CoV-2 and chikungunya infections, potentially via TGFβ, likely delaying recovering of lung function and promoting conditions for secondary infection and other age associated lung disorders (Uhrlaub et al., 2016; Goplen et al., 2020; Goplen et al., 2021; Shenoy and Mizgerd, 2021). Interestingly, within the lung environment, we have also shown that resident effector CD8+ T cells demonstrate a robust innate-like response, driven by an IL-12 dependent but antigen-independent secretion of IFNγ (Vesosky et al., 2006a; Vesosky et al., 2006b; Rottinghaus et al., 2009; Vesosky et al., 2009). Such CD8 effector cells were shown to play a role in early innate control of M. tuberculosis infection in old mice (Vesosky et al., 2006a; Rottinghaus et al., 2009; Vesosky et al., 2009). The relevance of such cells is not clear, but it is thought to be a compensatory mechanism to establish an additional defense barrier against respiratory pathogens in the elderly (Piergallini and Turner, 2018b), but could equally be one that interferes with optimal antigen specific immunity or perhaps contributes to lung tissue damage that has long term consequences on pulmonary function with increasing age. The study of adaptive immune cells specifically in the lung during aging, in the context of chronic disease such as chronic obstructive pulmonary disease or asthma, is an as yet understudied area (Lee et al., 2012) but lung tissue specificity and age-associated changes likely also play a contributing role to the ability of T and B cells to exert their immune control as we age.

Discussion

Aging is accompanied by a decline in immune efficacy resulting in increased vulnerability to infections. There is increasing evidence that immune dysfunction linked to exacerbated inflammatory reactivity is associated with failure in organ systems (ex: lung, brain, skeletal muscle) leading to functional decline, morbidity and mortality. Several of these syndromes and diseases such as frailty, dementia, cardiovascular disease and cancer, result in elderly persons being dependent on others for daily living. Immune decline occurs at different ages, and can be influenced by host genetics as well as external “perturbations” such as metabolic status (e.g., dysglycemia) and lifetime exposure to pathogens. The mechanisms underlying these alterations are poorly understood; where it is unclear which changes are primary consequences of aging, and which are compensatory. Furthermore, it is unclear if inflammaging begins in the periphery and spills over into organs such as the lung or vice versa. Answering these questions is critical for the development and implementation of therapeutics that delay, prevent or restore an individual’s age-related decrease in immunity, including its associated failure of organ systems. Elucidation of these interactions is best accomplished through longitudinal studies spanning decades, which are logistically challenging and costly. Alternatives are cross-sectional studies in individuals of all ages, or short longitudinal assessments of individuals challenged by an “insult” to their immune system that accelerates aging of their immune cells. These studies in humans present interpretation challenges due to high levels of variability in factors of interest that may underlie responsivity to challenges, for example patients with undiagnosed dysglycemia which is the most prevalent metabolic perturbation in the elderly (Chia et al., 2018; Scordo et al., 2021).

We postulate that there is a gradual increase in inflammation and altered metabolism across the aging continuum, potentially initiated in the pulmonary space, which is directly exposed to environmental insults, that culminates in a cascade of organ and systemic dysfunctions, reaching a peak or tipping point(s) where inflammation and oxidation can no longer be reversed by interventions (Figure 2). Modulating cellular oxidative stress-related factors that occur during inflammaging in the alveolus prior to the tipping point(s) may allow for the restoration and maintenance of healthy immune and metabolic homeostasis during aging.